Vicarious Surgical Inc.

NYSE: RBOT · Real-Time Price · USD
7.35
-0.48 (-6.13%)
At close: Aug 14, 2025, 3:58 PM
7.53
2.45%
Pre-market: Aug 15, 2025, 08:46 AM EDT

Vicarious Surgical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.09M 2.09M 2.09M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
2.33M 2.44M 2.6M 2.08M 2.02M 2.13M 2.25M 2.32M 2.41M 1.96M 1.5M 910K 455K 269K 84K 84K n/a n/a
Gross Profit
-244K -355K -507K -2.08M -2.02M -2.13M -2.25M -2.32M -2.41M -1.96M -1.5M -1.04M -581K -395K -210K -84K n/a n/a
Operating Income
-62M -66.19M -66.56M -67.12M -70.72M -74.46M -80.67M -85.73M -86.55M -84.21M -80.08M -77.29M -63.69M -51.17M -38.22M -24.19M -18.97M -15.42M
Interest Income
2.11M 2.76M 3.29M 3.66M 3.81M 3.93M 4.43M 4.29M 3.84M 2.9M 1.44M 622K 128K 28K 21K 2K 3K 23K
Pretax Income
-59.63M -61.62M -63.22M -62.41M -61.02M -61.15M -71.07M -69.14M -78.17M -64.29M 5.16M 58.48M 38.09M 32.91M -12.8M -58.73M -16.95M -13.36M
Net Income
-59.63M -61.62M -63.22M -62.41M -61.02M -61.15M -71.07M -69.14M -78.17M -64.29M 5.16M 58.48M 38.09M 32.91M -12.8M -58.73M -16.95M -13.36M
Selling & General & Admin
24.27M 26.59M 26.4M 26.96M 28.32M 30.27M 33.09M 34.75M 36.48M 36.8M 36.18M 36.01M 29.34M 22.87M 16.16M 8.42M 5.88M 4.04M
Research & Development
37.73M 39.6M 39.63M 39.64M 41.88M 43.67M 47.58M 50.99M 50.07M 47.41M 43.9M 41.32M 34.39M 28.34M 22.1M 15.77M 13.08M 11.39M
Other Expenses
n/a n/a 521K 521K 521K 521K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
62M 66.19M 66.56M 67.12M 70.72M 74.46M 80.67M 85.73M 86.55M 84.21M 80.08M 77.29M 63.69M 51.17M 38.22M 24.19M 18.97M 15.42M
Interest Expense
n/a n/a n/a 22K 23K 24K 25K 114K 144K 172K 200K 119K 119K 117K 89K 59K 29K 2K
Selling & Marketing Expenses
3.58M 4.42M 4.53M 4.75M 4.94M 5.41M 6.23M 6.87M 7.38M 7.02M 6.46M 6.19M 5.12M 4.14M 2.96M 1.48M 998K 854K
Cost & Expenses
62M 66.19M 66.56M 67.12M 70.72M 74.46M 80.67M 85.73M 86.55M 84.21M 80.08M 77.29M 63.69M 51.17M 38.22M 24.19M 18.97M 15.42M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 26K -1.63M -1.63M -1.63M -1.66M
Shares Outstanding (Basic)
5.94M 5.92M 5.91M 5.9M 5.87M 5.35M 5.83M 5.17M 4.23M 4.2M 4.11M 4.06M 4.04M 4.01M 3.97M 3.07M 2.76M 3.95M
Shares Outstanding (Diluted)
5.94M 5.92M 5.91M 5.9M 5.87M 5.37M 5.83M 5.17M 4.23M 4.2M 4.11M 4.06M 4.04M 4.25M 3.97M 3.07M 2.92M 3.95M
EPS (Basic)
-10.09 -10.45 -11.03 -10.92 -11.06 -12.09 -15.21 -15.66 -18.62 -15.36 1.44 21.81 13.11 11.07 -1.23 -20.21 -6.68 -4.83
EPS (Diluted)
-10.09 -10.45 -11.02 -10.91 -11.05 -12.08 -15.21 -15.66 -18.62 -15.36 0.84 21.21 12.51 10.60 -1.1 -20.08 -6.55 -4.83
EBITDA
-58.87M -60.01M -60.22M -59.4M -58.08M -58.1M -68.8M -66.9M -75.81M -62.36M 6.67M 59.63M 38.79M 33.48M -14.45M -60.48M -18.82M -15.3M
EBIT
-59.98M -61.97M -62.33M -61.49M -60.11M -60.23M -71.05M -69.03M -78.03M -64.12M 5.36M 58.6M 38.21M 33.02M -14.76M -60.72M -18.97M -15.42M
Depreciation & Amortization
1.83M 1.94M 2.09M 2.08M 2.02M 2.13M 2.25M 2.32M 2.41M 1.96M 1.5M 1.04M 581K 459K 315K 235K 189K 163K